Sherbrooke Park Advisers’s Boston Scientific BSX Stock Holding History

Sherbrooke Park Advisers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$243K	Sell	2,549 -10,652	-81%	-$1.04M	0.63%	57
2025 Q3	$1.29M	Buy	13,201 +8,135	+161%	+$842K	0.6%	11
2025 Q2	$544K	Buy	5,066 +1,288	+34%	+$130K	0.24%	145
2025 Q1	$381K	Sell	3,778 -4,933	-57%	-$497K	0.18%	214
2024 Q4	$778K	Buy	8,711 +5,385	+162%	+$474K	0.25%	102
2024 Q3	$279K	Buy	+3,326	New	+$262K	0.06%	602
2024 Q1	–	Sell	-21,545	Closed	-$1.25M	–	845
2023 Q4	$1.25M	Buy	21,545 +1,137	+6%	+$60.7K	0.59%	20
2023 Q3	$1.08M	Sell	20,408 -18,738	-48%	-$983K	0.34%	94
2023 Q2	$2.12M	Buy	39,146 +24,446	+166%	+$1.28M	1.11%	3
2023 Q1	$735K	Buy	+14,700	New	+$693K	1.11%	14

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sherbrooke Park Advisers's BSX Position: Q4 2025 in Review

Sherbrooke Park Advisers reduced its Boston Scientific (BSX) stake by 81% in Q4 2025, selling an estimated $1.04M and leaving 2,549 shares worth $243K. The position accounts for 0.63% of the portfolio, ranked #57.

Sherbrooke Park Advisers first reported a position in BSX in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.12M in Q2 2023. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Sherbrooke Park Advisers held 2,549 shares of Boston Scientific worth $243K as of Q4 2025.
Sherbrooke Park Advisers sold 10,652 Boston Scientific shares in Q4 2025, an estimated $1.04M.
Boston Scientific made up 0.63% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #57 holding.
Sherbrooke Park Advisers first reported a position in Boston Scientific in Q1 2023 and has held it in 10 quarters since.
Sherbrooke Park Advisers's Boston Scientific position peaked at $2.12M in Q2 2023.
1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.